Role of the progesterone receptor for paclitaxel resistance in primary breast cancer

Paclitaxel plays an important role in the treatment of primary breast cancer. However, a substantial proportion of patients treated with paclitaxel does not appear to derive any benefit from this therapy. We performed a prospective study using tumour cells isolated from 50 primary breast carcinomas....

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, M, Bremer, E, Hasenclever, D, Victor, A, Gehrmann, M, Steiner, E, Schiffer, I B, Gebhardt, S, Lehr, H-A, Mahlke, M, Hermes, M, Mustea, A, Tanner, B, Koelbl, H, Pilch, H, Hengstler, J G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359989/
https://www.ncbi.nlm.nih.gov/pubmed/17211474
http://dx.doi.org/10.1038/sj.bjc.6603538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359989/
https://www.ncbi.nlm.nih.gov/pubmed/17211474
http://dx.doi.org/10.1038/sj.bjc.6603538

Ejemplares similares